Literature DB >> 28329729

Prodrugs of triterpenoids and their derivatives.

Meng Zhou1, Rong-Hong Zhang2, Min Wang3, Guo-Bo Xu4, Shang-Gao Liao5.   

Abstract

Triterpenoids are structurally diverse organic compounds that exist widely as natural products. Triterpenoids and their derivatives possess a wide range of biological effects including hepatoprotective, hypoglycemic, immunomodulatory, anti-inflammatory, anti-oxidant, and antitumor activities. In particular, the lupane-, oleanane-, and ursane-type triterpenes have been reported to exhibit pharmacological effects without prominent toxicity even at higher concentrations. Whereas, the poor drug-like properties (e.g., low solubility and selectivity, poor bioavailability, and short half-life) severely limit their applications. This review summarized the advances in prodrug strategies for improving the drug-like properties of different types of triterpenoids, and the information indicated in the review will surely stimulate further efforts toward the development of these compounds for potential clinical uses.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Drug-like property; Prodrugs; Triterpenoids

Mesh:

Substances:

Year:  2017        PMID: 28329729     DOI: 10.1016/j.ejmech.2017.03.005

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  9 in total

1.  Characterization of naturally occurring pentacyclic triterpenes as novel inhibitors of deubiquitinating protease USP7 with anticancer activity in vitro.

Authors:  Bo Jing; Meng Liu; Li Yang; Hai-Yan Cai; Jie-Bo Chen; Ze-Xi Li; Xi Kou; Yun-Zhao Wu; Dong-Jun Qin; Li Zhou; Jin Jin; Hu Lei; Han-Zhang Xu; Wei-Wei Wang; Ying-Li Wu
Journal:  Acta Pharmacol Sin       Date:  2017-11-23       Impact factor: 6.150

2.  Microbial-Catalyzed Baeyer-Villiger Oxidation for 3,4-seco-Triterpenoids as Potential HMGB1 Inhibitors.

Authors:  Pingping Shen; Jing Zhou; Xuewa Jiang; Haixia Ge; Weiwei Wang; Boyang Yu; Jian Zhang
Journal:  ACS Omega       Date:  2022-05-25

Review 3.  Recent Achievements in Medicinal and Supramolecular Chemistry of Betulinic Acid and Its Derivatives .

Authors:  Uladzimir Bildziukevich; Zülal Özdemir; Zdeněk Wimmer
Journal:  Molecules       Date:  2019-09-30       Impact factor: 4.411

Review 4.  Pentacyclic Triterpenoids with Nitrogen-Containing Heterocyclic Moiety, Privileged Hybrids in Anticancer Drug Discovery.

Authors:  Vuyolwethu Khwaza; Sithenkosi Mlala; Opeoluwa O Oyedeji; Blessing A Aderibigbe
Journal:  Molecules       Date:  2021-04-21       Impact factor: 4.411

Review 5.  Pentacyclic Triterpenoids Isolated from Celastraceae: A Focus in the 13C-NMR Data.

Authors:  Karen Caroline Camargo; Mariana Guerra de Aguilar; Acácio Raphael Aguiar Moraes; Raquel Goes de Castro; Daiane Szczerbowski; Elizabeth Luciana Marinho Miguel; Leila Renan Oliveira; Grasiely Faria Sousa; Diogo Montes Vidal; Lucienir Pains Duarte
Journal:  Molecules       Date:  2022-01-31       Impact factor: 4.411

Review 6.  Clinical Application of Bioextracts in Supporting the Reproductive System of Animals and Humans: Potential and Limitations.

Authors:  Alicja Kowalczyk; Robert Kupczyński; Elżbieta Gałęska; Jose P Araujo; Ewa Czerniawska-Piątkowska
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-27       Impact factor: 2.629

7.  Glycosylated Zein Composite Nanoparticles for Efficient Delivery of Betulinic Acid: Fabrication, Characterization, and In Vitro Release Properties.

Authors:  Fei Peng; Yu Jin; Kunhua Wang; Xiaojing Wang; Yaqing Xiao; Huaide Xu
Journal:  Foods       Date:  2022-08-26

Review 8.  Technologies for Solubility, Dissolution and Permeation Enhancement of Natural Compounds.

Authors:  Meshal Alshamrani; Muhammad Khalid Khan; Barkat Ali Khan; Ahmad Salawi; Yosif Almoshari
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-25

9.  From Plant Compounds to Botanicals and Back: A Current Snapshot.

Authors:  Alessandra Durazzo; Laura D'Addezio; Emanuela Camilli; Raffaela Piccinelli; Aida Turrini; Luisa Marletta; Stefania Marconi; Massimo Lucarini; Silvia Lisciani; Paolo Gabrielli; Loretta Gambelli; Altero Aguzzi; Stefania Sette
Journal:  Molecules       Date:  2018-07-24       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.